Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1985 Mar;78(3):189–192. doi: 10.1177/014107688507800303

Neurotransmitter diversity and its functional significance.

F E Bloom
PMCID: PMC1289631  PMID: 2857791

Full text

PDF
189

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom F. E. Neurotransmitters and CNS disease. The future. Lancet. 1982 Dec 18;2(8312):1381–1385. doi: 10.1016/s0140-6736(82)91280-6. [DOI] [PubMed] [Google Scholar]
  2. Bloom F. E. The functional significance of neurotransmitter diversity. Am J Physiol. 1984 Mar;246(3 Pt 1):C184–C194. doi: 10.1152/ajpcell.1984.246.3.C184. [DOI] [PubMed] [Google Scholar]
  3. Buijs R. M., Van Heerikhuize J. J. Vasopressin and oxytocin release in the brain--a synaptic event. Brain Res. 1982 Dec 2;252(1):71–76. doi: 10.1016/0006-8993(82)90979-9. [DOI] [PubMed] [Google Scholar]
  4. Foote S. L., Bloom F. E., Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev. 1983 Jul;63(3):844–914. doi: 10.1152/physrev.1983.63.3.844. [DOI] [PubMed] [Google Scholar]
  5. Greengard P. Phosphorylated proteins as physiological effectors. Science. 1978 Jan 13;199(4325):146–152. doi: 10.1126/science.22932. [DOI] [PubMed] [Google Scholar]
  6. Guillemin R., Brazeau P., Böhlen P., Esch F., Ling N., Wehrenberg W. B. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 1982 Nov 5;218(4572):585–587. doi: 10.1126/science.6812220. [DOI] [PubMed] [Google Scholar]
  7. Guillemin R. Peptides in the brain: the new endocrinology of the neuron. Science. 1978 Oct 27;202(4366):390–402. doi: 10.1126/science.212832. [DOI] [PubMed] [Google Scholar]
  8. Nicoll R. A., Schenker C., Leeman S. E. Substance P as a transmitter candidate. Annu Rev Neurosci. 1980;3:227–268. doi: 10.1146/annurev.ne.03.030180.001303. [DOI] [PubMed] [Google Scholar]
  9. Reuter H. Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature. 1983 Feb 17;301(5901):569–574. doi: 10.1038/301569a0. [DOI] [PubMed] [Google Scholar]
  10. Siggins G. R., Zieglgänsberger W. Morphine and opioid peptides reduce inhibitory synaptic potentials in hippocampal pyramidal cells in vitro without alteration of membrane potential. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5235–5239. doi: 10.1073/pnas.78.8.5235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Snyder S. H. Brain peptides as neurotransmitters. Science. 1980 Aug 29;209(4460):976–983. doi: 10.1126/science.6157191. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES